Novartis, Vectura lung drugs face delay in U.S.
by on Oct.25, 2011, under Uncategorized
Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the Swiss drugmaker said on Tuesday, in an update with third-quarter results.
View full post on Yahoo! Health News
